Welcome to our dedicated page for Therealreal SEC filings (Ticker: REAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The RealReal, Inc. (REAL) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as an online marketplace for authenticated, resale luxury goods. This SEC filings page aggregates those documents so readers can review how the company reports its financial performance, capital structure and key corporate events.
Core periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) provide detail on revenue streams, including consignment revenue, direct revenue and shipping services revenue, along with discussions of gross merchandise value, margins, net income or loss and non-GAAP measures like Adjusted EBITDA. These filings also contain sections such as “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which the company cites in its earnings releases.
Current reports on Form 8-K offer more immediate updates on material events. For The RealReal, recent 8-K filings have addressed quarterly earnings announcements, debt exchange transactions involving convertible senior notes, and changes in the composition of the board of directors. These documents also confirm that the company’s common stock, with a par value of $0.00001 per share, is listed on The Nasdaq Global Select Market under the symbol REAL.
On Stock Titan, each REAL filing is paired with AI-powered summaries designed to explain the key points in accessible language. Readers can quickly see what changed in a new 10-K or 10-Q, how a Form 8-K alters the company’s obligations or governance, and where Form 4 insider transaction reports fit into the broader picture. Real-time updates from EDGAR help ensure that new filings appear promptly, while AI-generated highlights make it easier to navigate complex regulatory documents related to The RealReal’s luxury resale business.
Form 4 snapshot: On 07/23/2025, The RealReal, Inc. (REAL) director James R. Miller acquired 26,025 common shares through settlement of deferred restricted stock units (DRSUs) at $0 cost. The award is part of the company’s equity-based compensation plan rather than an open-market purchase.
Following the settlement, Miller now directly owns 183,916 shares. No derivative securities, sales, or additional purchases were reported. The filing contains no operational or financial updates; it simply records the change in beneficial ownership required under Section 16.
Because the shares were issued under an existing plan, the transaction is considered routine with negligible dilution. It modestly increases insider ownership but lacks the stronger bullish signal of a cash-funded purchase, leaving the overall investment thesis unchanged.
TheRealReal, Inc. (REAL) – Form 4 insider filing
Director Caretha Coleman reported the grant of 26,025 deferred restricted stock units (DRSUs) on 07/23/2025. Each DRSU converts into one share of REAL common stock upon settlement; the grant carried a stated price of $0, indicating an equity-based compensation award rather than an open-market purchase. Following the award, Coleman's direct beneficial ownership rises to 251,783 shares, further aligning the director’s economic interest with shareholders. No derivative securities were involved and no dispositions were reported.
The filing is routine compensation-related and does not include any earnings data or guidance. While the additional shares modestly increase insider ownership, the absence of cash consideration or open-market buying means the signal for outside investors is limited.
Form 4 snapshot: On 07/23/2025, The RealReal, Inc. (REAL) filed a Form 4 showing Director Niki Leondakis acquired 26,025 shares of common stock via settlement of deferred restricted stock units (DRSUs). The transaction was coded “A,” signifying an equity award rather than an open-market purchase, and carried a stated price of $0.
After the grant, Leondakis’ direct holdings increased to 206,112 shares. No derivative securities were involved and no shares were disposed of. Although the filing expands insider ownership and can be viewed as modestly positive for shareholder alignment, it reflects routine compensation and therefore has limited market impact.